TET2 and non-small cell lung carcinoma: Additionally, TET2 has been identified as a key player in the resistance mechanisms of various cancers, such as non-small cell lung cancer, suggesting that drugs aimed at restoring TET2 function could be effective in overcoming therapeutic resistance (70).